Pasithea Therapeutics Corp Stock Last Dividend Paid
KTTAW Stock | USD 0.03 0 16.33% |
Pasithea Therapeutics Corp fundamentals help investors to digest information that contributes to Pasithea Therapeutics' financial success or failures. It also enables traders to predict the movement of Pasithea Stock. The fundamental analysis module provides a way to measure Pasithea Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pasithea Therapeutics stock.
Pasithea | Last Dividend Paid |
Pasithea Therapeutics Corp Company Last Dividend Paid Analysis
Pasithea Therapeutics' Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Pasithea Last Dividend Paid Driver Correlations
Understanding the fundamental principles of building solid financial models for Pasithea Therapeutics is extremely important. It helps to project a fair market value of Pasithea Stock properly, considering its historical fundamentals such as Last Dividend Paid. Since Pasithea Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Pasithea Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Pasithea Therapeutics' interrelated accounts and indicators.
Click cells to compare fundamentals
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
CompetitionPasithea Dividend Paid And Capex Coverage Ratio
Dividend Paid And Capex Coverage Ratio |
|
Based on the recorded statements, Pasithea Therapeutics Corp has a Last Dividend Paid of 0.0. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
All Next | Launch Module |
Pasithea Fundamentals
Return On Equity | -0.63 | ||||
Return On Asset | -0.38 | ||||
Revenue | 486.56 K | ||||
EBITDA | (15.33 M) | ||||
Net Income | (15.51 M) | ||||
Cash And Equivalents | 568.98 K | ||||
Cash Per Share | 0.07 X | ||||
Total Debt | 81.68 K | ||||
Current Ratio | 37.55 X | ||||
Book Value Per Share | 22.46 X | ||||
Cash Flow From Operations | (13.43 M) | ||||
Beta | 0.82 | ||||
Total Asset | 26.12 M | ||||
Retained Earnings | (35.32 M) | ||||
Working Capital | 14.06 M | ||||
Net Asset | 26.12 M |
About Pasithea Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pasithea Therapeutics Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pasithea Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pasithea Therapeutics Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Pasithea Stock Analysis
When running Pasithea Therapeutics' price analysis, check to measure Pasithea Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pasithea Therapeutics is operating at the current time. Most of Pasithea Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pasithea Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pasithea Therapeutics' price. Additionally, you may evaluate how the addition of Pasithea Therapeutics to your portfolios can decrease your overall portfolio volatility.